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In the early 1990s, one of us was involved in one of the
first projects to sequence a bacterial genome, the meager
1.1 Mb chromosome of Treponema pallidum, the causa-
tive agent of syphilis. Completing the project ultimately
took about seven years (until published in 1998 [1]),
over US$1.8 million in National Institutes of Health
grants (R01AI031068 and R01AI040390) [2], and re-
quired pooling forces with The Institute for Genomic
Research. Recently, that original T. pallidum strain was
re-sequenced to get a ‘perfect’ sequence, a process that
took a few days and cost only hundreds of dollars [3].
The original sequencing was performed with the
dideoxy-chain termination technique using slab gel elec-
trophoresis instruments. Newly developed software was
used for genome assembly and data management and
analysis. The latter re-sequencing was performed with
next-generation sequencing (NGS) technology and ma-
ture software tools. Such is the enormous progress in
microbial genome sequencing in the last 20 years.
The mind-boggling evolution of DNA sequencing and
bioinformatics technologies is driving a new era of patho-
gen research. Recent studies of old, well-scrutinized path-
ogens are now greatly extended based on the sequencing
of thousands of strains from collections [4,5]. This in-
creased density of genetic data for individual species
allows new insights and definition of mechanisms, just
as an aerial photograph gives a clearer picture of the
landscape as the pixel density increases. Such large-scale
studies, now possible with the increased throughput and
lower cost of sequencing, allow a more comprehensive
picture of a species’ gene pool (the pan-genome), popu-
lation genetic and/or evolutionary analyses, and more
accurate insights into epidemiology, to name a few ad-
vances. In the realm of epidemiology, NGS of pathogens
is now pushing into the applied genomics area of the
clinic, with, for example, studies of clinical outbreaks
that can now precisely define complex transmission* Correspondence: george.weinstock@jax.org
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creativecommons.org/publicdomain/zero/1.0/)chains [6,7]. Perilous clinical challenges posed by new
antibiotic-resistant organisms benefit from NGS which
can identify mutations, thereby defining mechanisms by
which resistance is acquired [8,9], as well as discerning
new threats from resistance genes found in whole gen-
ome sequences [10].
It is in this context of a new era in pathogen genomics
that this special issue of Genome Biology and Genome
Medicine on the Genomics of Infectious Diseases has been
assembled. It coincides with an exhilarating time for
pathogen genomics research and covers a broad range of
bacterial, viral, and parasitic pathogens. Genomic analysis,
and sequencing in particular, is agnostic, and applies
equally well to the diverse types of pathogens studied in
this special issue. Pathogen genomics continues to be an
area of some urgency. We need look no further than the
current challenges of containing Ebola virus outbreaks or
the emergence and expansion of new antibiotic-resistant
bacteria, such as carbapenemase-producing Klebsiella
pneumoniae, to be reminded that infectious disease is
not, and will never be, a solved problem. Rather, only by
dramatic technological innovation, such as offered by NGS,
can we keep up with the pathogenic population.
Genome sequencing continues to advance and provide
new tools and applications for pathogen research. Se-
quencing can now be performed on hundreds of strains
in parallel in overnight instrument runs, and this drives
forward the data density for the description of genomes
and gene expression patterns. Metagenomic application
of NGS is another bright new area, affording new culture-
independent detection of pathogens in clinical samples as
well as illuminating interactions between the pathogen
and resident microbiome. One looks forward to future
applications of this information to combat infection
and restore health, possibly with reduced dependence
on antibiotics.Abbreviation
NGS: Next-generation sequencing.Competing interests
The authors declare that they have no competing interests.ed Central Ltd. The licensee has exclusive rights to distribute this article, in any
n. After this time, the article is available under the terms of the Creative Commons
/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
erly credited. The Creative Commons Public Domain Dedication waiver (http://
applies to the data made available in this article, unless otherwise stated.
Weinstock and Peacock Genome Biology 2014, 15:528 Page 2 of 2
http://genomebiology.com/2014/15/11/528Author details
1The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
2Department of Medicine, University of Cambridge, Box 157 Addenbrooke’s
Hospital, Hills Road, Cambridge CB2 0QQ, UK. 3The Wellcome Trust Sanger
Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
References
1. Fraser CM, Norris SJ, Weinstock GM, White O, Sutton GG, Dodson R, Gwinn M,
Hickey EK, Clayton R, Ketchum KA, Sodergren E, Hardham JM, McLeod MP,
Salzberg S, Peterson J, Khalak H, Richardson D, Howell JK, Chidambaram M,
Utterback T, McDonald L, Artiach P, Bowman C, Cotton MD, Fujii C, Garland S,
Hatch B, Horst K, Roberts K, Sandusky M, et al: Complete genome sequence
of Treponema pallidum, the syphilis spirochete. Science 1998, 281:375–388.
2. NIH RePORTER [http://projectreporter.nih.gov/reporter.cfm?def=1]
3. Pětrošová H, Pospíšilová P, Strouhal M, Čejková D, Zobaníková M, Mikalová L,
Sodergren E, Weinstock GM, Smajs D: Resequencing of Treponema pallidum
ssp. pallidum strains Nichols and SS14: correction of sequencing errors
resulted in increased separation of syphilis treponeme subclusters.
PLoS One 2013, 8:e74319.
4. Chewapreecha C, Marttinen P, Croucher NJ, Salter SJ, Harris SR, Mather AE,
Hanage WP, Goldblatt D, Nosten FH, Turner C, Bentley SD, Parkhill J:
Comprehensive identification of single nucleotide polymorphisms
associated with beta-lactam resistance within pneumococcal mosaic
genes. PLoS Genet 2014, 10:e1004547.
5. Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW, Kristinsson KG,
Gottfredsson M, Vuopio J, Raisanen K, Caugant DA, Steinbakk M, Low DE,
McGeer A, Darenberg J, Henriques-Normark B, Van Beneden CA, Hoffmann S,
Musser JM: Evolutionary pathway to increased virulence and epidemic
group A Streptococcus disease derived from 3,615 genome sequences.
Proc Natl Acad Sci U S A 2014, 111:E1768–1776.
6. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Group NCSP, Henderson DK,
Palmore TN, Segre JA: Tracking a hospital outbreak of carbapenem-resistant
Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012,
4:148ra116.
7. Koser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart AL,
Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, Sanders M, Enright MC,
Dougan G, Bentley SD, Parkhill J, Fraser LJ, Betley JR, Schulz-Trieglaff OB,
Smith GP, Peacock SJ: Rapid whole-genome sequencing for investigation of
a neonatal MRSA outbreak. N Engl J Med 2012, 366:2267–2275.
8. Tran TT, Panesso D, Gao H, Roh JH, Munita JM, Reyes J, Diaz L, Lobos EA,
Shamoo Y, Mishra NN, Bayer AS, Murray BE, Weinstock GM, Arias CA:
Whole-genome analysis of a daptomycin-susceptible Enterococcus
faecium strain and its daptomycin-resistant variant arising during
therapy. Antimicrob Agents Chemother 2013, 57:261–268.
9. Tran TT, Panesso D, Mishra NN, Mileykovskaya E, Guan Z, Munita JM, Reyes J,
Diaz L, Weinstock GM, Murray BE, Shamoo Y, Dowhan W, Bayer AS, Arias CA:
Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule
from the division septum and remodels cell membrane phospholipids.
MBio 2013, 4:e00281–13.
10. Rossi F, Diaz L, Wollam A, Panesso D, Zhou Y, Rincon S, Narechania A, Xing G,
Di Gioia TS, Doi A, Tran TT, Reyes J, Munita JM, Carvajal LP, Hernandez-Roldan A,
Brandão D, van der Heijden IM, Murray BE, Planet PJ, Weinstock GM, Arias CA:
Transferable vancomycin resistance in a community-associated MRSA lineage.
N Engl J Med 2014, 370:1524–1531.
doi:10.1186/s13059-014-0528-6
Cite this article as: Weinstock and Peacock: Next-generation pathogen
genomics. Genome Biology 2014 15:528.
